Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies.

Hany Ariffin Edwynn Kean Hui ChiewBernice Ling Zhi OhShawn Hsien Ren LeeEvelyn Huizi LimShirley Kow Yin KhamWan Ariffin AbdullahLee Lee ChanKoon Mian FooJoyce Ching Mei LamYiong Huak ChanHai Peng LinThuan Chong QuahAh Moy TanAllen Eng-Juh Yeoh

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

In comparison with MS2003-SR, the anthracycline-free MS2010-SR protocol is not inferior and was less toxic as treatment for favorable-risk childhood BCP-ALL.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
randomized controlled trial
early life
young adults